Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation

Human Pathology

Volumn 39, Issue 11, 2008, Pages 1695-1701

  Pohjolainen, Virva ^a   Taskinen, Panu ^b   Soini, Ylermi ^b   Rysä, Jaana ^a   Ilves, Mika ^a   Juvonen, Tatu ^b   Ruskoaho, Heikki ^a   Leskinen, Hanna ^a   Satta, Jari ^b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aortic valve stenosis; Bone matrix proteins; Calcification

Indexed keywords

BONE MATRIX PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; OSTEOPONTIN; OSTEOPROTEGERIN; PROTEIN; SIALOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY LABELING; AORTA VALVE; AORTA VALVE CALCIFICATION; AORTA VALVE DISEASE; ARTICLE; BONE MATRIX; BONE MINERALIZATION; BONE REMODELING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEINS; CALCINOSIS; CARDIOMYOPATHIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OSTEOPONTIN; OSTEOPROTEGERIN; SIALOGLYCOPROTEINS;

EID: 53849089554     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.04.015     Document Type: Article

References (28)

1. Freeman R.V., and Otto C.M. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111 (2005) 3316-3326
2. Soini Y., Salo T., and Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum Pathol 34 (2003) 756-763
3. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., and O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90 (1994) 844-853
4. Mohler III E.R., Gannon F., Reynolds C., et al. Bone formation and inflammation in cardiac valves. Circulation 103 (2001) 1522-1528
5. Speer M.Y., and Giachelli C.M. Regulation of cardiovascular calcification. Cardiovasc Pathol 13 (2004) 63-70
6. Price P.A., Faus S.A., and Williamson M.K. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18 (1998) 1400-1407
7. O'Brien K.D., Kuusisto J., Reichenbach D.D., et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 92 (1995) 2163-2168
8. Srivatsa S.S., Harrity P.J., Maercklein P.B., et al. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 99 (1997) 996-1009
9. Rajamannan N.M., Subramaniam M., Rickard D., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107 (2003) 2181-2184
10. Kaden J.J., Bickelhaupt S., Grobholz R., et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 36 (2004) 57-66
11. Hruska K.A., Mathew S., and Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 97 (2005) 105-114
12. Dhore C.R., Cleutjens J.P., Lutgens E., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21 (2001) 1998-2003
13. Chirgwin J.M., Przybyla A.E., MacDonald R.J., and Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 (1979) 5294-5299
14. Majalahti-Palviainen T., Hirvinen M., Tervonen V., et al. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology 141 (2000) 731-740
15. Luo G., Ducy P., McKee M.D., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (1997) 78-81
16. Steitz S.A., Speer M.Y., McKee M.D., et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161 (2002) 2035-2046
17. Bucay N., Sarosi I., Dunstan C.R., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12 (1998) 1260-1268
18. Rutsch F., Vaingankar S., Johnson K., et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 158 (2001) 543-554
19. Alford A.I., and Hankenson K.D. Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 38 (2006) 749-757
20. Speer M.Y., McKee M.D., Guldberg R.E., et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196 (2002) 1047-1055
21. Ohri R., Tung E., Rajachar R., and Giachelli C.M. Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin. Calcif Tissue Int 76 (2005) 307-315
22. Ganss B., Kim R.H., and Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 10 (1999) 79-98
23. Bellahcene A., Bonjean K., Fohr B., et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 86 (2000) 885-891
24. Kaden J.J., Bickelhaupt S., Grobholz R., et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis 13 (2004) 560-566
25. Wang J., Zhou H.Y., Salih E., et al. Site-specific in vivo calcification and osteogenesis stimulated by bone sialoprotein. Calcif Tissue Int 79 (2006) 179-189
26. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
27. Bennett B.J., Scatena M., Kirk E.A., et al. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol 26 (2006) 2117-2124
28. Luppen C.A., Smith E., Spevak L., Boskey A.L., and Frenkel B. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 18 (2003) 1186-1197